MoveDMD Trial Open-Label Extension Results (October 2017) PPMD and Catabasis Pharmaceuticals hosted a webinar on October 11, 2017 to hear a community update on the results from the open-label extension of the MoveDMD trial. Research & Clinical Trial Webinars,Webinars 7 years ago You may also like 49:31 Edgewise Therapeutics: A Novel Approach Designed to Protect Muscle in Becker Muscular Dystrophy 1 year ago Research & Clinical Trial Webinars,Webinars edg-5506,edgewise 59:38 Supporting Families Through Decision Making 1 year ago Care Webinars,Webinars palliative care 52:31 Affinity Duchenne™ and Affinity Beyond™: Updates on Investigational RGX-202 from REGENXBIO 1 year ago Research & Clinical Trial Webinars,Webinars 31:23 Advocating for Access: Insurance 101 1 year ago Care Webinars,Webinars 29:12 Advocating for Access: Navigating Approved Therapies in Duchenne 1 year ago Care Webinars,Webinars 1:11:00 Webinar: ELEVIDYS Approval: What this means for you and your family 1 year ago Care Webinars,Webinars 46:01:00 Webinar: ENVISION Study Update with Sarepta Therapeutics 2 years ago Research & Clinical Trial Webinars,Webinars 37:54 Community Town Hall: SRP-9001 Advisory Committee Update (May 2023) 2 years ago Research & Clinical Trial Webinars,Webinars «123456…25»Page 4 of 25